AU3167993A - Ligands and binding partner for treatment and diagnosis of inflammatory conditions - Google Patents

Ligands and binding partner for treatment and diagnosis of inflammatory conditions

Info

Publication number
AU3167993A
AU3167993A AU31679/93A AU3167993A AU3167993A AU 3167993 A AU3167993 A AU 3167993A AU 31679/93 A AU31679/93 A AU 31679/93A AU 3167993 A AU3167993 A AU 3167993A AU 3167993 A AU3167993 A AU 3167993A
Authority
AU
Australia
Prior art keywords
ligands
diagnosis
treatment
binding partner
inflammatory conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31679/93A
Inventor
Jo Michelle Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of AU3167993A publication Critical patent/AU3167993A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU31679/93A 1991-12-19 1992-12-21 Ligands and binding partner for treatment and diagnosis of inflammatory conditions Abandoned AU3167993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9126918 1991-12-19
GB919126918A GB9126918D0 (en) 1991-12-19 1991-12-19 Members of specific binding pairs;methods of their making and using

Publications (1)

Publication Number Publication Date
AU3167993A true AU3167993A (en) 1993-07-19

Family

ID=10706501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31679/93A Abandoned AU3167993A (en) 1991-12-19 1992-12-21 Ligands and binding partner for treatment and diagnosis of inflammatory conditions

Country Status (3)

Country Link
AU (1) AU3167993A (en)
GB (1) GB9126918D0 (en)
WO (1) WO1993012248A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0615129B1 (en) * 1993-03-10 2000-05-31 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitis
US5830675A (en) * 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
US5681699A (en) * 1994-02-11 1997-10-28 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and Crohn's disease
US6884590B1 (en) 1994-02-11 2005-04-26 Cedars-Sinai Medical Center Methods of screening for ulcerative colitis and crohn's disease
US5738847A (en) * 1994-09-19 1998-04-14 The Regents Of The University Of California Anti-VH3-15 reagents and methods for their use
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
EP3639841B1 (en) 2013-03-27 2023-09-06 Cedars-Sinai Medical Center Treating fibrosis by inhibiting tl1a
EP4105236A1 (en) 2013-07-19 2022-12-21 Cedars-Sinai Medical Center Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease
WO2017161342A1 (en) 2016-03-17 2017-09-21 Cedars-Sinai Medical Center Methods of diagnosing inflammatory bowel disease through rnaset2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314863B1 (en) * 1987-11-02 1994-12-07 Baylor College Of Medicine Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma

Also Published As

Publication number Publication date
GB9126918D0 (en) 1992-02-19
WO1993012248A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
AU7336891A (en) Fitted mattress cover and method of making same
AU7905894A (en) Treatment of poultry
AU1532492A (en) Use of heterocyclic compounds for the treatment of inflammatory pain
AU584590B2 (en) Zinc complexes of hydroxypyrones and hydroxypyridones
AU642762B2 (en) Method of treating inflammatory bowel disease
AU4009795A (en) Heterocyclic compounds and their use
AU3167993A (en) Ligands and binding partner for treatment and diagnosis of inflammatory conditions
AU5543494A (en) Method and kit for cancer diagnosis
AU2821295A (en) Compositions and methods for the treatment of tumors
EP0557388A4 (en) Diagnosis and treatment of multiple sclerosis
AU8192691A (en) Method of treatment and compositions therefore
AU1097192A (en) Treatment of particulate material
AU8427091A (en) Gamma-carboxylase and methods of use
AU1279788A (en) Compounds and treatment
AU3574395A (en) Magnetic treatment of fluids
AU8574591A (en) Treatment of peptic ulcer
AU3553489A (en) Novel compounds and treatment
AU549565B2 (en) L (-) carnotine hydrochloride and l (-) carnotine inner salt
AU8879691A (en) Treatment of dispersions
AU6205798A (en) Bissteroidal compounds and their use for the preparation of chiral complexes
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU8113091A (en) Method of treatment of allergic conjunctivitis
AU6270794A (en) Treatment of allergic responses using mhc-peptide complexes